Top Healthcare Stocks

The Healthcare sector presents a mixed quality picture through the Tessera lens. With a sector median quality score of 68 against a universe average of 48, Healthcare as a whole sits meaningfully above the broader screener population — but the top-ranked individual names within this particular qualifying cohort tell a more cautious story, with scores clustered in a narrow band between 0.45 and 0.55, indicating no standout high-conviction names at the top of the list.

The sector's median P/E of 29.8 reflects the premium valuation investors have historically extended to healthcare businesses, though that multiple demands scrutiny when applied to early-stage or clinical-phase companies. NRXP leads the qualifying group with a score of 0.55, followed closely by PTIXW at 0.51 and ZIVOW at 0.49 — all three carrying the hallmarks of speculative-stage biotechnology, where quality scoring tends to be constrained by limited earnings histories, binary pipeline risks, and capital-intensive operating structures. IMGN and ARAV round out the top five within a similarly compressed scoring range.

Across the full 492 qualifying Healthcare members, the sector's aggregate quality score of 68 positions it notably above the 48 universe median, suggesting that Healthcare, taken broadly, screens as a structurally higher-quality segment relative to the overall Tessera universe — even as the individual names surfacing at the top of this particular screen reflect the more speculative end of that sector's spectrum.